Skip Content

OK to Ask Campaign for 2015

24 May 2015

Research is key to improving survival rates and finding cures for pancreatic cancer; and clinical trials are a vital part of the research

As the US National Cancer Institute says, “Well-designed, well-run clinical trials are the only way to determine the true effectiveness of a promising new agent or intervention being investigated.”

The start of this year’s National Institute for Health Research (NIHR) ‘OK to Ask’ campaign coincided with International Clinical Trials Day on 20 May. It's aimed at encouraging more patients or carers to ask about research opportunities that could be available to them or their loved ones when they use the NHS.

PCRF supporter Philippe Ariaudo told us of his wife Bobbie's participation in pancreatic cancer clinical research: "Bobbie took part in a clinical trial as she thought it was vitally important that progress was made to help increase the chances for those in the future who had this terrible disease. It probably gave her at least an extra 6 months for which we are eternally grateful."

A recent survey conducted by the NIHR Clinical Research Network showed that 95 per cent of people surveyed said it was important to them that the NHS carries out clinical research but fewer than 21 per cent said they would feel very confident about asking their doctor about research opportunities.

NIHR’s national ‘OK to Ask’ campaign is about encouraging many more people to ask their doctor or consultant about accessing research as part of their care and treatment and highlighting that they have a right to information about ‘relevant and appropriate’ research under the NHS Constitution.

You can find out about pancreatic cancer trials here

< Back